inSteps, born as a spin-off from the University of Amsterdam, is now taking its official form as inSteps B.V.. The company employs in-silico modelling technology, aimed at propelling advancements in the treatment of severe strokes. After participating in the Proefdiervrij Venture Challenge 2022 last year and finishing its preparatory phase with seed funding, inSteps looks ahead, harbouring objectives for its future in the world of healthcare innovation.
Request a free consultation
Contact us to learn how our platform can help optimize your medical device development and clinical trial designs.